Gene · 5481
Papers1,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Loss of cyclophilin D prolyl isomerase activity desensitizes mitochondrial permeability transition pore opening in isolated cardiac mitochondria, but does not protect in myocardial ischemia-reperfusion injury. | J Mol Cell Cardiol | 2023 | 37696137 | PubTator, text mining | PubMed |
| S100A6: molecular function and biomarker role. | Biomark Res | 2023 | 37670392 | PubTator, text mining | PubMed |
| Mitochondrial dynamics in health and disease: mechanisms and potential targets. | Signal Transduct Target Ther | 2023 | 37669960 | PubTator, text mining | PubMed |
| Protective effects of ginseng and ginsenosides in the development of osteoarthritis (Review). | Exp Ther Med | 2023 | 37664679 | PubTator, text mining | PubMed |
| Special Issue "Stem Cell Biology & Regenerative Medicine". | Int J Mol Sci | 2023 | 37629035 | PubTator, text mining | PubMed |
| Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration? | Biomolecules | 2023 | 37627330 | PubTator, text mining | PubMed |
| ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. | Sci Adv | 2023 | 37624892 | PubTator, text mining | PubMed |
| A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM. | JACC Asia | 2023 | 37614533 | PubTator, text mining | PubMed |
| Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. | Exp Mol Med | 2023 | 37612409 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Esculetin-Furoxan-DEAC Ternary Hybrids for Anti-Triple Negative Breast Cancer. | J Med Chem | 2023 | 37602711 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks. | Front Aging Neurosci | 2023 | 37600514 | PubTator, text mining | PubMed |
Early and Dose-Dependent Xenogeneic Mesenchymal Stem Cell Therapy Improved Outcomes in Acute Respiratory Distress Syndrome Rodent Through Ameliorating Inflammation, Oxidative Stress, and Immune Reaction. | Cell Transplant | 2023 | 37592717 | PubTator, text mining | PubMed |
| Computer-Aided Designing Peptide Inhibitors of Human Hematopoietic Prostaglandin D2 Synthase Combined Molecular Docking and Molecular Dynamics Simulation. | Molecules | 2023 | 37570903 | PubTator, text mining | PubMed |
| Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence. | Asian J Urol | 2023 | 37538166 | PubTator, text mining | PubMed |
| Potential enhancement of post-stroke angiogenic response by targeting the oligomeric aggregation of p53 protein. | Front Cell Neurosci | 2023 | 37534043 | PubTator, text mining | PubMed |
| Microplitis bicoloratus Bracovirus Promotes Cyclophilin D-Acetylation at Lysine 125 That Correlates with Apoptosis during Insect Immunosuppression. | Viruses | 2023 | 37515179 | PubTator, text mining | PubMed |
| Recent Progress in the Characterization, Synthesis, Delivery Procedures, Treatment Strategies, and Precision of Antimicrobial Peptides. | Int J Mol Sci | 2023 | 37511621 | PubTator, text mining | PubMed |
| The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer's Disease. | Biomolecules | 2023 | 37509087 | PubTator, text mining | PubMed |
| Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities. | Biology (Basel) | 2023 | 37508437 | PubTator, text mining | PubMed |
| The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease. | J Alzheimers Dis | 2023 | 37393492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5481/papers?page=4